Inhibiting Fatty Acid Oxidation Suppresses Acquired Resistance to Standard Chemotherapy in Melanoma.
Saved in:
| Title: | Inhibiting Fatty Acid Oxidation Suppresses Acquired Resistance to Standard Chemotherapy in Melanoma. |
|---|---|
| Authors: | Choi W; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Republic of Korea.; Division of Cancer Biology, Research Institute of National Cancer Center, Goyang 10408, Republic of Korea.; Therapeutic Resistance Research Branch, Research Institute and Hospital, National Cancer Center, Goyang 10408, Republic of Korea., Ham W; Division of Cancer Biology, Research Institute of National Cancer Center, Goyang 10408, Republic of Korea.; New Cancer Cure-Bio Co., Goyang 10408, Republic of Korea., Park JH; Division of Cancer Biology, Research Institute of National Cancer Center, Goyang 10408, Republic of Korea.; New Cancer Cure-Bio Co., Goyang 10408, Republic of Korea., Sim SH; Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea., Chun JW; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Republic of Korea.; Division of Clinical Research, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.; Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang 10408, Republic of Korea., Kang M; Division of Cancer Biology, Research Institute of National Cancer Center, Goyang 10408, Republic of Korea.; New Cancer Cure-Bio Co., Goyang 10408, Republic of Korea., Kim C; Division of Cancer Biology, Research Institute of National Cancer Center, Goyang 10408, Republic of Korea.; New Cancer Cure-Bio Co., Goyang 10408, Republic of Korea., Hong W; Division of Cancer Biology, Research Institute of National Cancer Center, Goyang 10408, Republic of Korea.; New Cancer Cure-Bio Co., Goyang 10408, Republic of Korea., Koh EB; Division of Cancer Biology, Research Institute of National Cancer Center, Goyang 10408, Republic of Korea., Kang JH; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Republic of Korea.; New Cancer Cure-Bio Co., Goyang 10408, Republic of Korea., Woo SM; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, Goyang 10408, Republic of Korea.; Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of Korea.; Center for Liver and Pancreatobiliary Cancer, National Cancer Center, Goyang 10408, Republic of Korea., Kim SY; Division of Cancer Biology, Research Institute of National Cancer Center, Goyang 10408, Republic of Korea.; New Cancer Cure-Bio Co., Goyang 10408, Republic of Korea. |
| Source: | International journal of molecular sciences [Int J Mol Sci] 2025 Oct 10; Vol. 26 (20). Date of Electronic Publication: 2025 Oct 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1422-0067 |
|---|---|
| DOI: | 10.3390/ijms26209873 |
